Cargando…
COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)
SARS-CoV-2 emerged in December 2019 and led to the COVID-19 pandemic. Efforts to develop therapeutics have led to innovations such as mRNA vaccines and oral antivirals. Here we provide a narrative review of the biologic therapeutics used or proposed to treat COVID-19 during the last 3 years. This pa...
Autores principales: | Chary, Michael, Barbuto, Alexander F., Izadmehr, Sudeh, Tarsillo, Marc, Fleischer, Eduardo, Burns, Michele M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979891/ https://www.ncbi.nlm.nih.gov/pubmed/36862334 http://dx.doi.org/10.1007/s13181-023-00931-9 |
Ejemplares similares
-
COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Xenobiotics)
por: Chary, Michael A., et al.
Publicado: (2022) -
COVID-19: Therapeutics and Their Toxicities
por: Chary, Michael A., et al.
Publicado: (2020) -
SUN-143 Prostatic Acid Phosphatase Is Not Regulated by Androgens During Prostate Development and Tumorigenesis
por: Izadmehr, Sudeh, et al.
Publicado: (2020) -
Prostatic Acid Phosphatase Is a Progenitor Cell Marker That Persists After Androgen Ablation
por: Izadmehr, Sudeh, et al.
Publicado: (2021) -
SAT-328 Androgens Modulate the Expression of Prostatic Acid Phosphatase
por: Izadmehr, Sudeh, et al.
Publicado: (2019)